Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102947000A details Z-M-OR complexes for efficient C-H and N-H carboxylation. Enables sustainable API intermediate synthesis using renewable CO2 feedstock.
Patent CN110845547A details novel Pd-catalyzed asymmetric alkylation. Offers high ee values and mild conditions for indole derivatives manufacturing.
Patent CN109761875B reveals a high-yield Rh-catalyzed method for indole-3-carboxamides, offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Patent CN109776529B reveals a green, catalyst-free route for 1,2-diketone imidazoles, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN107879911A reveals aqueous silver-catalyzed synthesis. Reduces cost and environmental impact for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN111718245A reveals a green method for deuterated chemicals using h-BCN photocatalysis, offering cost reduction and mild conditions for pharma intermediates.
Patent CN103450280A reveals a one-step route to high-purity palladium precursors, eliminating chloride contamination and reducing manufacturing costs for industrial catalysts.
Patent CN106946887A details catalyst optimization for Dipyridamole. Enhances yield and safety while reducing environmental impact for reliable supply chains.
Patent CN111285769B details a polyionic liquid copper catalyst for efficient, green aqueous Henry reactions, offering high enantioselectivity and simplified supply chains for pharmaceutical intermediates.
Novel FeCl3-catalyzed oxidative coupling for 3,3'-diindoles. High purity, scalable process for API intermediates. Cost-effective manufacturing solution.
Novel catalyst-free method for high-purity thiophene derivatives using inorganic sulfides. Reduces cost and complexity in electronic chemical manufacturing.
Patent CN115784826B reveals nickel-catalyzed olefin functionalization. Offers cost reduction in pharmaceutical intermediate manufacturing with high selectivity.
Patent CN111484533B discloses novel Ir-SpiroPNP catalysts achieving 99.8% ee in dialkyl ketone hydrogenation, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110294689B details a green ruthenium-catalyzed method for converting primary amines to nitriles with high yield and hydrogen byproduct.
Novel 3,4-diaminopyridine catalyst enables high-yield asymmetric synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes globally.
Patent CN119874773B reveals advanced ligand enhancing conversion stability. Delivers supply chain reliability and cost optimization for global chemical manufacturing.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Patent CN112824374B details a nickel-catalyzed asymmetric hydrogenation method for chiral amines, offering cost-effective alternatives to precious metals for pharmaceutical intermediates.
Patent CN105693726B details a mild synthesis route for catalyst ligands. Achieve cost reduction in specialty chemical manufacturing with reliable supply chains.
Patent CN104725266B reveals high-yield imide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.